United States · FDA National Drug Code directory
GABAPENTIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72189-158_2becf606-de3d-b686-e063-6294a90afe58
- Product NDC
- 72189-158
- Form
- TABLET, FILM COATED
- Composition / generic term
- GABAPENTIN
- Labeler
- DIRECT RX
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201201
- Source listing expiry
- 20261231
Source-listed ingredients
- GABAPENTIN — 800 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (72189-158-30) · 72189-158-30
- 60 TABLET, FILM COATED in 1 BOTTLE (72189-158-60) · 72189-158-60
- 120 TABLET, FILM COATED in 1 BOTTLE (72189-158-72) · 72189-158-72
- 90 TABLET, FILM COATED in 1 BOTTLE (72189-158-90) · 72189-158-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →